Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells
Therapeutic resistance seen in aggressive forms of breast cancer remains challenging for current treatments. More than half of the patients suffer from a disease relapse, most of them with distant metastases. Cancer maintenance, resistance to therapy, and metastatic disease seem to be sustained by t...
Main Authors: | Petra Gener, Diana Rafael, Joaquin Seras-Franzoso, Anna Perez, Luis Alamo Pindado, Glòria Casas, Diego Arango, Yolanda Fernández, Zamira V. Díaz-Riascos, Ibane Abasolo, Simó Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1058 |
Similar Items
-
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
by: Jean Paul Vernot
Published: (2020-05-01) -
Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
by: Junli Deng, et al.
Published: (2019-06-01) -
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
by: Chiara Agnoletto, et al.
Published: (2019-04-01) -
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
by: Diana Rafael, et al.
Published: (2018-01-01) -
HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells
by: Qing Zhou, et al.
Published: (2021-01-01)